Kate Cuschieri (United Kingdom)

NHS Lothian Scottish HPV Reference Lab

Kate is lead for the HPV research group at the University of Edinburgh & Director of the Scottish HPV Reference Laboratory in NHS Lothian. She is a consultant clinical scientist and has an interest in the identification, monitoring and prevention of HPV driven disease, including non cervical disease. She is also Hon Lecturer at the Universities of Edinburgh and Glasgow

Presenter of 3 Presentations

Conference Calendar

Workshop 2: Screening / Treatment Hall B

The challenges for quality assuring HPV based primary screening programmes (ID 84)

Session Date

07/20/2020

Session Time

11:00 - 12:25

Room

Hall B

Session Type

Public Health

Session Name

Workshop 2: Screening / Treatment

Lecture Time

11:43 - 12:03

Presenter

Kate Cuschieri (United Kingdom)

Authors

Kate Cuschieri (United Kingdom)

HPV testing in low- and middle income countries Hall A

Validation of the Xpert HPV assay (Cepheid) and the careHPV assay (Qiagen) (ID 1570)

Session Date

07/23/2020

Session Time

10:40 - 11:45

Room

Hall A

Session Type

Dedicated Symposium

Session Name

HPV testing in low- and middle income countries

Lecture Time

10:58 - 11:13

Presenter

Kate Cuschieri (United Kingdom)

Authors

Kate Cuschieri (United Kingdom)

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 4: Triage Approaches for HPV-Positive Women Hall C

LONGITUDINAL CLINICAL PERFORMANCE OF TRIAGE STRATEGIES FOR THE RISK STRATIFICATION OF PRIMARY HPV INFECTION; AN UPDATE FROM THE PAVDAG COHORT (ID 569)

Session Date

07/22/2020

Session Time

08:45 - 10:00

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 4: Triage Approaches for HPV-Positive Women

Lecture Time

09:00 - 09:12

Presenter

Kate Cuschieri (United Kingdom)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Moderator of 1 Session

Conference Calendar

Dedicated Symposium

00890 - HPV testing in low- and middle income countries (ID 154)

Session Type

Dedicated Symposium

Session Date

07/23/2020

Session Time

10:40 - 11:45

Room

Hall A

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"Introduction by Chairs \u003Csmall\u003E(ID 1714)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1714,"presentation":"Introduction by Chairs \u003Csmall\u003E(ID 1714)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Marc Arbyn (Belgium)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/2141.jpg"},"playlist":[{"name":"ntroduction by Chairs","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC20 1714 Introduction by Chairs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC20 1714 Introduction by Chairs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/4E81BEAD.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC20 1714 Introduction by Chairs.vtt"}]},{"name":"Principles of validation of HPV assays usable in low-resource countries. \u003Csmall\u003E(ID 1569)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1569,"presentation":"Principles of validation of HPV assays usable in low-resource countries. \u003Csmall\u003E(ID 1569)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Marc Arbyn (Belgium)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/2141.jpg"},"playlist":[{"name":"Principles of validation of HPV assays usable in low-resource countries.","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC2020 P_1569.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC2020 P_1569.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/BF68D0D.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Marc Arbyn IPVC2020 P_1569.vtt"}]},{"name":"Validation of the Xpert HPV assay (Cepheid) and the careHPV assay (Qiagen) \u003Csmall\u003E(ID 1570)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1570,"presentation":"Validation of the Xpert HPV assay (Cepheid) and the careHPV assay (Qiagen) \u003Csmall\u003E(ID 1570)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Kate Cuschieri (United Kingdom)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/73.jpg"},"playlist":[{"name":"Validation of the Xpert HPV assay (Cepheid) and the careHPV assay (Qiagen)","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Kate Cuschieri IPVC20 1570.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/Kate Cuschieri IPVC20 1570.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/7355C419.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Kate Cuschieri IPVC20 1570.vtt"}]},{"name":"Validation of Chinese new HPV assays \u003Csmall\u003E(ID 1571)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1571,"presentation":"Validation of Chinese new HPV assays \u003Csmall\u003E(ID 1571)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Youlin Qiao (China)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/446.jpg"},"playlist":[{"name":"Youlin Qiao - IPVC20 - Presentation 1,571","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Youlin Qiao - IPVC20 - P 1571.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/Youlin Qiao - IPVC20 - P 1571.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/B3A2A0BA.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/Youlin Qiao - IPVC20 - P 1571.vtt"}]},{"name":"Validation of assays used for screening or triage in the Estampa study \u003Csmall\u003E(ID 1572)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1572,"presentation":"Validation of assays used for screening or triage in the Estampa study \u003Csmall\u003E(ID 1572)\u003C\/small\u003E","session":"HPV testing in low- and middle income countries","presenter":"Maribel Almonte (France)","photo":""},"playlist":[{"name":"Validation of assays used for screening or triage in the Estampa study","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/DA4D5473.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/154\/GMT20200710-155733_Maribel-Al_1920x1020-0.vtt"}]}]